|
|
Volumn 285, Issue 5434, 1999, Pages
|
|
Cancer research. A new way to combat therapy side effects.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZOTHIAZOLE DERIVATIVE;
DRUG DERIVATIVE;
PIFITHRIN;
PROTEIN P53;
THIAZOLE DERIVATIVE;
TOLUENE;
ANIMAL;
APOPTOSIS;
CELL CULTURE;
CELL DIVISION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG SCREENING;
GAMMA RADIATION;
HUMAN;
MOUSE;
NEOPLASM;
NOTE;
PHYSIOLOGY;
RADIATION DOSE;
RADIATION EXPOSURE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BENZOTHIAZOLES;
CELL DIVISION;
CELLS, CULTURED;
DRUG EVALUATION, PRECLINICAL;
GAMMA RAYS;
HUMANS;
MICE;
NEOPLASMS;
RADIATION DOSAGE;
RADIATION TOLERANCE;
THIAZOLES;
TOLUENE;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
|
EID: 0033543395
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.285.5434.1651a Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
